Ultrasound-facilitated, catheter-directed thrombolysis versus anticoagulation alone for acute intermediate-high-risk pulmonary embolism: Rationale and design of the HI-PEITHO study.

[1]  R. Redberg,et al.  Coverage of Transvenous Pulmonary Embolectomy - Medicare's Missed Opportunity for Evidence Generation. , 2021, The New England journal of medicine.

[2]  E. Vicaut,et al.  Reduced-Dose Intravenous Thrombolysis for Acute Intermediate–High-risk Pulmonary Embolism: Rationale and Design of the Pulmonary Embolism International THrOmbolysis (PEITHO)-3 trial , 2021, Thrombosis and Haemostasis.

[3]  S. Stevens,et al.  Antithrombotic Therapy for VTE Disease: Second Update of the CHEST Guideline and Expert Panel Report. , 2021, Chest.

[4]  M. Chuang,et al.  Indigo Aspiration System for Treatment of Pulmonary Embolism: Results of the EXTRACT-PE Trial. , 2021, JACC. Cardiovascular interventions.

[5]  I. Schmidtmann,et al.  In-hospital outcomes of catheter-directed thrombolysis in patients with pulmonary embolism. , 2020, European heart journal. Acute cardiovascular care.

[6]  W. Ageno,et al.  American Society of Hematology 2020 guidelines for management of venous thromboembolism: treatment of deep vein thrombosis and pulmonary embolism. , 2020, Blood advances.

[7]  W. Ageno,et al.  Age-sex specific pulmonary embolism-related mortality in the USA and Canada, 2000–18: an analysis of the WHO Mortality Database and of the CDC Multiple Cause of Death database , 2020, The Lancet Respiratory Medicine.

[8]  T. Münzel,et al.  EkoSonic® endovascular system and other catheter-directed treatment reperfusion strategies for acute pulmonary embolism: overview of efficacy and safety outcomes , 2020, Expert review of medical devices.

[9]  G. Escobar,et al.  Comparison of Early Warning Scoring Systems for Hospitalized Patients With and Without Infection at Risk for In-Hospital Mortality and Transfer to the Intensive Care Unit , 2020, JAMA network open.

[10]  P. Prandoni,et al.  Measuring functional limitations after venous thromboembolism: Optimization of the Post-VTE Functional Status (PVFS) Scale. , 2020, Thrombosis research.

[11]  W. Ageno,et al.  Trends in mortality related to pulmonary embolism in the European Region, 2000-15: analysis of vital registration data from the WHO Mortality Database. , 2020, The Lancet. Respiratory medicine.

[12]  M. Humbert,et al.  2019 ESC Guidelines for the diagnosis and management of acute pulmonary embolism developed in collaboration with the European Respiratory Society (ERS): supplementary data , 2019 .

[13]  G. Washko,et al.  Quantification and Significance of Pulmonary Vascular Volume in Predicting Response to Ultrasound-Facilitated, Catheter-Directed Fibrinolysis in Acute Pulmonary Embolism (SEATTLE-3D). , 2019, Circulation. Cardiovascular imaging.

[14]  R. Yeh,et al.  Utilization and Outcomes of Thrombolytic Therapy for Acute Pulmonary Embolism: A Nationwide Cohort Study. , 2019, Chest.

[15]  F. A. Klok,et al.  Immediate and late impact of reperfusion therapies in acute pulmonary embolism , 2019, European heart journal supplements : journal of the European Society of Cardiology.

[16]  H. Krumholz,et al.  Pulmonary Embolism Hospitalization, Readmission, and Mortality Rates in US Older Adults, 1999-2015. , 2019, JAMA.

[17]  F. Klok,et al.  Measuring functional limitations after venous thromboembolism: A call to action. , 2019, Thrombosis research.

[18]  T. Münzel,et al.  Trends in thrombolytic treatment and outcomes of acute pulmonary embolism in Germany. , 2019, European heart journal.

[19]  K. Ouriel,et al.  A Prospective, Single-Arm, Multicenter Trial of Catheter-Directed Mechanical Thrombectomy for Intermediate-Risk Acute Pulmonary Embolism: The FLARE Study. , 2019, JACC. Cardiovascular interventions.

[20]  S. Goldhaber,et al.  A Randomized Trial of the Optimum Duration of Acoustic Pulse Thrombolysis Procedure in Acute Intermediate-Risk Pulmonary Embolism: The OPTALYSE PE Trial. , 2018, JACC. Cardiovascular interventions.

[21]  P. Reitsma,et al.  Pulmonary embolism , 2018, Nature Reviews Disease Primers.

[22]  T. Lange,et al.  Acute Pulmonary Embolism in a National Danish Cohort: Increasing Incidence and Decreasing Mortality , 2018, Thrombosis and Haemostasis.

[23]  E. Vicaut,et al.  Improved identification of thrombolysis candidates amongst intermediate-risk pulmonary embolism patients: implications for future trials , 2018, European Respiratory Journal.

[24]  R. Yusen,et al.  Efficacy and safety outcomes of recanalisation procedures in patients with acute symptomatic pulmonary embolism: systematic review and network meta-analysis , 2017, Thorax.

[25]  N. Devlin,et al.  EQ-5D and the EuroQol Group: Past, Present and Future , 2017, Applied Health Economics and Health Policy.

[26]  L. Dell’Italia,et al.  Catheter-directed treatment for acute pulmonary embolism: Systematic review and single-arm meta-analyses. , 2016, International journal of cardiology.

[27]  S. Vanni,et al.  Acute pulmonary embolism: mortality prediction by the 2014 European Society of Cardiology risk stratification model , 2016, European Respiratory Journal.

[28]  G. Raskob,et al.  Global Burden of Thrombosis: Epidemiologic Aspects. , 2016, Circulation research.

[29]  M. D. de Gregorio,et al.  Pulmonary Embolism Response to Fragmentation, Embolectomy, and Catheter Thrombolysis (PERFECT): Initial Results From a Prospective Multicenter Registry. , 2015, Chest.

[30]  S. Goldhaber,et al.  A Prospective, Single-Arm, Multicenter Trial of Ultrasound-Facilitated, Catheter-Directed, Low-Dose Fibrinolysis for Acute Massive and Submassive Pulmonary Embolism: The SEATTLE II Study. , 2015, JACC. Cardiovascular interventions.

[31]  M. Sebbane,et al.  Fibrinolysis for patients with intermediate-risk pulmonary embolism. , 2014, The New England journal of medicine.

[32]  Ralf-Thorsten Hoffmann,et al.  Randomized, Controlled Trial of Ultrasound-Assisted Catheter-Directed Thrombolysis for Acute Intermediate-Risk Pulmonary Embolism , 2014, Circulation.

[33]  Gary B. Smith,et al.  The ability of the National Early Warning Score (NEWS) to discriminate patients at risk of early cardiac arrest, unanticipated intensive care unit admission, and death. , 2013, Resuscitation.

[34]  Cyrus R Mehta,et al.  Adaptive increase in sample size when interim results are promising: A practical guide with examples , 2011, Statistics in medicine.

[35]  Marco Valgimigli,et al.  Standardized Bleeding Definitions for Cardiovascular Clinical Trials: A Consensus Report From the Bleeding Academic Research Consortium , 2011, Circulation.

[36]  J. Kline,et al.  Management of Massive and Submassive Pulmonary Embolism, Iliofemoral Deep Vein Thrombosis, and Chronic Thromboembolic Pulmonary Hypertension: A Scientific Statement From the American Heart Association , 2011, Circulation.

[37]  H. Büller,et al.  Quality of life after pulmonary embolism: validation of the PEmb‐QoL Questionnaire , 2010, Journal of thrombosis and haemostasis : JTH.

[38]  S. Goldhaber,et al.  Massive Pulmonary Embolism , 2006, Circulation.

[39]  S. Schulman,et al.  Definition of major bleeding in clinical investigations of antihemostatic medicinal products in non‐surgical patients , 2005, Journal of thrombosis and haemostasis : JTH.

[40]  ATS Statement , 2002 .

[41]  C. Sherbourne,et al.  The MOS 36-Item Short-Form Health Survey (SF-36) , 1992 .